Current treatment of acromegaly
Kawamata, T.; Amano, K.; Okada, Y.
No Shinkei Geka. Neurological Surgery 43(1): 17-28
2015
ISSN/ISBN: 0301-2603 PMID: 25557096 Document Number: 679299
Document emailed within 1 workday
Related Documents
Jaedig, S. 1982: Medical treatment of acromegaly with bromocriptine Ugeskrift for Laeger 144(47): 3514-3515Cáp, J.; Nemecek, S.; Rezácová, M.; Cerman, J. 2005: Possibilities of medical treatment in acromegaly Casopis Lekaru Ceskych 144(Suppl 3): 33-34; 36-37
Webb, S.; Oliver, B.; del Pozo, C.; Bartumeus, F. 1985: Treatment and criteria for cure of acromegaly Medicina Clinica 85(8): 341
Marek, J.; Bauer, J.; Srámková, J.; Hána, V. 1986: Terguride in the treatment of hyperprolactinemia and acromegaly Casopis Lekaru Ceskych 125(4): 100-105
Felt, V.; Nedvídková, J. 1985: Use of dironyl in the treatment of acromegaly and hyperprolactinemia Vnitrni Lekarstvi 31(10): 980-985
Páv, J.; Marek, J.; Srámková, J. 1986: The effect of acromegaly treatment on glucose tolerance Casopis Lekaru Ceskych 125(47): 1451-1454
Claure, H.; Bobadilla, E.; Veit, O.; Stevenson, C.; Donoso, P.; Chiorino, R. 1972: Treatment of acromegaly by stereotoxic implantation of yttrium-90 in the hypophysis Revista Medica de Chile 100(6): 621-624
Nilsson, A. 1978: Experiences with bromocriptine treatment in acromegaly--a preliminary report Acta Endocrinologica. Supplementum 216: 217-224
Pumar, A.; Santos, C.; García-Luna, P.P.; Acosta, D.; Pereira, J.L.; Gavilán, I.; Leal-Cerro, A.; Astorga, R. 1991: Results of trans-sphenoidal surgery for the treatment of acromegaly Revista Clinica Espanola 188(2): 76-80
Kanis, J.A.; Gillingham, F.J.; Harris, P.; Horn, D.B.; Hunter, W.M.; Redpath, A.T.; Strong, J.A. 1974: Clinical and laboratory study of acromegaly: assessment before and one year after treatment Quarterly Journal of Medicine 43(171): 409-431
Balabolkin, M.I.; Gerasimov, G.A.; Snigireva, R.I.; Gorokhova, T.R. 1989: Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome Klinicheskaia Meditsina 67(9): 89-92
Jannì, A.; Carmina, E.; Lanzara, P.; Lo Coco, R.; Longo, R.A. 1977: Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment La Clinica Terapeutica 82(3): 203-212
Hartmann, K.P.; Bottermann, P.; Souvatzoglou, A.; Hofmann, G.G.; Fahlbusch, B.; Kratzl, G.; Schwarz, K. 1971: Radioimmunological determination of growth hormone in patients with acromegaly before and following treatment Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 1037-1040
Sonka, K.; Weiss, V.; Dostálová, S.; Pretl, M.; Marek, J.; Horínek, D.; Faltýnová, E.; Rambousek, P.; Busek, P.; Hána, V. 1999: Sleep apnea syndrome in acromegaly. Treatment and development-- retrospective analysis Sbornik Lekarsky 100(1): 45-52
Migdalska, B.; Kasperlik-Załuska, A.; Wiśniewska-Woźniak, T.; Wisławski, J.; Hartwig, W. 1983: Surgical treatment of acromegaly by the trans-sphenoidal approach. II. Hormonal results Neurologia i Neurochirurgia Polska 17(1): 109-113
Besser, G.M.; Wass, J.A. 1978: Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years Medical Journal of Australia 2(3 Suppl): 31-33
Giusti, M.; Cuttica, C.M.; Cariola, G.; Valenti, S.; Sessarego, P.; Giordano, G. 1995: Treatment of acromegaly with octreotide: effectiveness and tolerability of its pulsatile administration by portable pump Recenti Progressi in Medicina 86(5): 189-194
Madsen, M.; Matthiesen, E.Boll.; Poulsen, P.Løgstrup.; Weeke, Jørgen.; Astrup, J.; Jørgensen, J.Otto.Lunde. 2007: Treatment of acromegaly in Aarhus University Hospital. A retrospective investigation of the period from 1994 to 2004 Ugeskrift for Laeger 169(10): 907-910
Zieliński, G.; Hendzel, P.; Szałański, Pław.; Gołowicz, Jław.; Gryszko, L.; Podgórski, J.Krzysztof. 2006: Severe cardiovascular complications due to the pituitary adenoma with acromegaly. An interdisciplinary approach to the treatment. A case report Neurologia i Neurochirurgia Polska 40(4): 354-360
Jaillon, P. 1986: Current therapeutic concepts in the treatment of myocardial ischemia. Current and future drugs Annales de Cardiologie et d'Angeiologie 35(7 Pt 2): 453-458